IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Proteon Therapeutics Inc

CUSIP: 7437IL109 | 1 institutional holders

Quarters

Q1 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2016

Opaleye Management Inc.150,000
0.0% of portfolio›$1.2K
StyleTurnoverLocationFiled
Opaleye Management Inc.
150,000$1.2K0.0%Agg GrowthMediumBoston, MA2016-05-27